Immunopathogenesis and spectrum of infections in systemic lupus erythematosus

Seminars in Arthritis and Rheumatism

Volumn 25, Issue 5, 1996, Pages 318-336

  Iliopoulos, A G ^a   Tsokos, G C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

immune defense; infection; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CORTICOSTEROID THERAPY; HUMAN; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT CARE; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029862632     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(96)80018-7     Document Type: Article

References (186)

1. Massardo R. Martinez M.E. Jacobelli S. Survival of Chilean patients with systemic lupus erythematosus Semin Arthritis Rheum 24 1994 1 11
2. Pistiner M. Wallace D.J. Nessim S. Lupus erythematosus in the 1980s: A survey of 570 patients Semin Arthritis Rheum 21 1991 55 64
3. Nossent J.C. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients Semin Arthritis Rheum 23 1993 16 21
4. Rosner S. Ginzler E. Diamond H. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death Arthritis Rheum 25 1982 612 617
5. Hellman D.B. Petri M. Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: The role of opportunistic organisms Medicine 66 1987 341 348
6. Rubin L.A. Urowitz M.B. Gladman D.D. Mortality in systemic lupus erythematosus: The bimodal pattern revisited Q J Med 55 1985 87 98
7. Futrell N. Schultz L. Millikan C. Central nervous system disease in patients with systemic lupus erythematosus Neurology 42 1992 1649 1657
8. Harvey A.M. Shulman L.E. Tumulty P.A. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases Medicine 33 1954 291 437
9. Petri M. Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins lupus cohort J Rheumatol 19 1992 1559 1565
10. Ginzler E. Diamond H. Kaplan D. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus Arthritis Rheum 21 1978 37 44
11. Turner-Stokes L. Isenberg D.A. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus Ann Rheum Dis 47 1988 529 531
12. Cope A.P. Jones A. Shafi M.S. Possible induction of systemic lupus erythematosus by human parvovirus Ann Rheum Dis 51 1992 803 804
13. Vigeant P. Menard H.-A. Boire G. Chronic modulation of the autoimmune response following parvovirus B19 infection J Rheumatol 21 1994 1165 1167
14. Chassagne P. Mejjad O. Gourmelen O. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection Br J Rheumatol 32 1993 158 159
15. Vasquez V. Barzaga R.A. Cunha B.A. Cytomegalovirus-induced flare of systemic lupus erythematosus Heart Lung 21 1992 407 408
16. Rubin R.H. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation JAMA 261 1989 3607 3609
17. Friedman S.M. Possnett D.N. Tumang J.R. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease Arthritis Rheum 34 1991 468 480
18. Behar S.M. Porcelli S.A. Mechanisms of autoimmune disease induction. The role of the immune response to microbial pathogens Arthritis Rheum 38 1995 458 476
19. Russo M.G. Waxman J. Abdoh A.A. Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome: A trigger mechanism? Arthritis Rheum 38 1995 374 380
20. Granholm N.A. Cavallo T. Autoimmunity, polyclonal B-cell activation and infection Lupus 1 1992 63 74
21. Cheigh J.S. Stenzel K.H. End-stage renal disease in systemic lupus erythematosus Am J Kidney Dis 21 1993 2 8
22. Shimamoto Y. Ohta A. Sano M. Improved or fatal acute disseminated intravascular coagulation in systemiclupus erythematosus Am J Hematol 42 1993 191 195
23. Van Der Straeten C. Wei N. Rothschild J. Rapidly fatal pneumococcal septicemia in systemic lupus erythematosus J Rheumatol 14 1987 1177 1180
24. Klemperer P. Pollack A.D. Baehr G. Pathology of disseminated lupus erythematosus Arch Pathol 32 1941 569 631
25. Ginzler E. Berg A. Mortality in systemic lupus erythematosus J Rheumatol 14 suppl 13 1987 218 222
26. Tsokos G.C. Ballow J.E. Cellular immune responses in systemic lupus erythematosus Prog Allerg 35 1984 93 161
27. Tsokos G.C. Overview of cellular immune function in systemic lupus erythematosus Lahita R.G. Systemic Lupus Erythematosus vol 2 1992 Churchill Livingstone New York, NY 15 50
28. Tsokos G.C. Lymphocytes, cytokines, inflammation and immune trafficking Curr Opin Rheumatol 6 1994 461 467
29. Via C.S. Allen R.C. Welton R.C. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: A relationship to disease activity J Rheumatol 11 1984 745 753
30. Roberts P.J. Isenberg D.A. Segal A.W. Defective degradation of bacterial DNA by phagocytes from patients with systemic and discoid lupus erythematosus Clin Exp Immunol 69 1987 68 78
31. Boswell J. Schur P.H. Monocyte function in systemic lupus erythematosus Clin Immunol Immunopathol 52 1989 271 278
32. Yu C.-L. Chang K.-L. Chiu C.-C. Defective phagocytosis, decreased tumour necrosis factor-a production; and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infection Stand J Rheumatoi 18 1989 97 105
33. Gyimesi E. Kavai M. Kiss E. Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus Clin Exp Immunol 94 1993 140 144
34. Boros P. Muryoi T. Spiera H. Autoantibodies directed against different classes of FcgR are found in sera of autoimmune patients J Immunol 150 1993 2018 2024
35. Kimberly R.P. Salmon J.E. Edberg J.C. Receptors for immunoglobulin G: Molecular diversity and implications for disease Arthritis Rheum 38 1995 306 314
36. Keeling D.M. Isenberg D.A. Haematological manifestations of systemic lupus erythematosus Blood Rev 7 1993 199 207
37. Rustagi P.K. Currie M.S. Logue G.L. Complement-activating antineutrophil antibody in systemic lupus erythematosus Am J Med 78 1985 971 977
38. Zurier R.B. Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus Arthritis Rheum 19 1976 73 78
39. Nived O. Linder C. Odeberg H. Reduced opsonization of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus Ann Rheum Dis 44 1985 252 259
40. Perez D.H. Hooper C. Volanakis J. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B J Immunol 139 1987 484 489
41. Hartman K.R. Wright D.G. Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CDllb/CD18 in patients with autoimmune neutropenia Blood 78 1991 1096 1104
42. (abstr, suppl 1) Hartman K.R. Klipple G. Tsokos G.C. Evidence for antibodies to the neutrophil aM/b2 integrin glycoproteins in patients with systemic lupus erythematosus Blood 84 1993 135a
43. Hartman K.R. LaRussa V.F. Rothwell S.W. Antibodies to myeloid precursor cells in autoimmune neutropenia Blood 84 1994 625 631
44. Lee S.S. Lawton J.W.M. Chan C.E. Antilactoferrin antibody in systemic lupus erythematosus Br J Rheumatol 31 1992 669 673
45. Schnabel A. Csernok E. Isenberg D.A. Antineutophil cytoplasmic antibodies in systemic lupus eythematosus Arthritis Rheum 38 1995 633 637
46. Boxer L.A. Coates T.D. Haak R.A. Lactoferrin deficiency associated with altered granulocyte function N Engl J Med 307 1982 404 410
47. Porges A.J. Redecha P.B. Kimberly W.T. Antineutrophil cytoplasmic antibodies engage and activate human neutrophils via FcgRIIa J Immunol 153 1994 1271 1280
48. Winfield J.B. Mimura T. Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus Clin Immunol Immunopathol 63 1992 13 16
49. Sfikakis P.P. Oglesby R. Tsokos G.C. B7/BBI provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus Clin Exp Immunol 94 1993 423 428
50. Stohl W. Impaired generation of polyclonal T cellmediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus Clin Immunol Immunopathol 63 1992 163 172
51. Stohl W. Impaired polyclonal T cell cytolytic activity: A possible risk factor for systemic lupus erythematosus Arthritis Rheum 38 1995 506 516
52. Via C.S. Tsokos G.C. Bermas B. T cell-antigenpresenting cell interactions in human systemic lupus erythematosus J Immunol 151 1993 3914 3922
53. Bermas B.L. Petri M. Goldman D. T helper cell dysfunction in systemic lupus erythematosus (SLE): Relation to disease activity J Clin Immunol 14 1994 169 177
54. Erkeller-Yusel F. Hulstaart F. Hannet I. Lymphocyte subsets in a large cohort of patients with systemic lupus eruthematosus Lupus 2 1993 227 231
55. Tsokos G.C. Lymphocyte abnormalities in human lupus Clin Immunol Immunopathol 63 1992 7 9
56. Nived O. Johanson I. Sturfelt G. Effects of ultraviolet irradation on natural killer cell function in systemic lupus erythematosus Ann Rheum Dis 51 1992 726 730
57. Croft S.M. Schiffman G. Snyder E. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus J Rheumatol 11 1984 141 146
58. Lipnick R.N. Karsh J. Stahl N.I. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives J Rheumatol 12 1985 1118 1121
59. McDonald E. Jarret M.P. Schiffman G. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus J Rheumatol 11 1984 306 308
60. Tsokos G.C. Smith P.L. Balow J.E. Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus Am J Med 81 1986 1081 1084
61. Cronin M.E. Balow J.E. Tsokos G.C. Immunoglobulin deficiency in patients with systemic lupus erythematosus Clin Exp Rheum 7 1988 359 364
62. Kay R.A. Wood K.J. Bernstein R.M. An IgG subclass imbalance in connective tissue disease Ann Rheum Dis 47 1988 536 541
63. Huston D.P. Kavanaugh A.F. Rohane P.W. Immunoglobulin deficiency syndromes and therapy J Allergy Clin Immunol 87 1991 1 17
64. Kaye B.R. Rheumatic manifestation of infection with human immunodeficiency virus Ann Intern Med 111 1989 158 167
65. (letter) Lindstrom F. Eriksson P. Denneberg T. IgG2 deficiency in patients with hypergammaglobulinaemia Lancet 340 1992 979
66. Liorente L. Zou W. Levy Y. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J Exp Med 181 1995 839 844
67. Mitchell S.R. Nguyen P.Q. Katz P. Increased risk of neisserial infections in systemic lupus erythematosus Semin Arthritis Rheum 20 1990 174 184
68. Yoshida K. Yukiyama Y. Miyamoto T. Quantification of the complement receptor function on polymorphonuclear leucocytes: Its significance in patients with systemic lupus erythematosus J Rheumatol 14 1987 490 496
69. Wilson J.G. Ratnoff W.D. Schur P.H. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CRl on neutrophils of patients with systemic lupus erythematosus Arthritis Rheum 29 1986 739 747
70. Yu C.-L. Tsai C.-Y. Chiu C.-C. Defective expression of neutrophil C3b receptors and impaired lymphocyte Na+ -K+ -ATPase activity in patients with systemic lupus erythematosus Proc Natl Sci Counc 15 1991 178 185
71. Wilson J.G. Jack R.M. Wong W.W. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus J Clin Invest 76 1985 182 190
72. (letter) Mir A. Balsalobre B. Inhibition of complementdependent phagocytosis by autoantibodies against C3breceptor (CRI) in a case of systemic lupus erythematosus J Intern Med 235 1994 284 285
73. Levy E. Ambrus J. Kahl L. T lymphocyte expression of complement receptor 2 (CR2/CD21): A role in adhesive cell-cell interactions and dysregulation in a patient with systemiclupus erythematosus Clin Exp Immunol 90 1992 235 244
74. Buyon J.P. Shadick N. Berkman R. Surface expression of Gpl65/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus Clin Immunol Immunopathol 46 1988 141 149
75. Piliero P. Furie F. Functional asplenia in systemic lupus erythematosus Semin Arthritis Rheum 20 1990 185 189
76. Frank M.M. Hamburger M.I. Lawley T.J. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus N Engl J Med 300 1979 518 523
77. Belmont H.M. Hopkins P. Edelson H.S. Complement activation during systemic lupus erythematosus Arthritis Rheum 29 1986 1085 1089
78. Anand A.J. Glatt A.E. Salmonella osteomyelitis and arthritis in sickle cell disease Semin Arthritis Rheum 24 1994 211 221
79. Kahl L.E. The spectrum of pericardial tamponade in systemic lupus erythematosus Arthritis Rheum 35 1992 1343 1349
80. Balow J.E. Austin H.A. Tsokos G.C. Lupus nephritis Ann Intern Med 106 1987 79 94
81. Donadio J.V. Glassock R.J. Immunosuppressive drug therapy in lupus nephritis Am J Kidney Dis 21 1993 239 250
82. Austin H.A. Klippel J.H. Balow J.E. Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 1986 614 619
83. Cohen J. Pinching A.J. Rees A.J. Infection and immunosuppression Q J Med 201 1982 1 15
84. Staples P. Gerding D. Decker J. Incidence of infection in systemic lupus erythematosus Arthritis Rheum 17 1974 1 10
85. Al-Hadithy H. Isenberg D.A. Addition I.E. Neutrophil function in systemic lupus erythematosus and other collagen diseases Ann Rheum Dis 41 1982 33 38
86. Salmon J.E. Kapur S. Meryhew N.L. High-dose, pulse intravenous methylprednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus Arthritis Rheum 32 1989 717 725
87. Steinberg A.D. Steinberg S.C. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treatedwith prednisone only Arthritis Rheum 34 1991 945 950
88. McCune W.J. Golbus J. Zeldes W. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus N Engl J Med 318 1988 1423 1431
89. Haag-Weber M. Horl W.H. Uremia and infection: Mechanisms of impaired cellular host defense Nephron 63 1992 125 131
90. Borg T.J. Horst G. Limburg P.C. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study J Rheumatol 17 1990 1642 1648
91. Abramson S. Dobro J. Eberle M.A. Acute reversible hypoxemia in systemic lupus erythematosus Ann Intern Med 114 1991 941 947
92. Caldwell J.R. Furst D.E. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis Semin Arthritis Rheum 21 1991 1 11
93. Boghossian S.H. Isenberg D.A. Wright G. Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus Ann Rheum Dis 43 1984 541 550
94. Leong K.H. Boey M.L. Feng P.H. Coexisting Pheumocystis carinii pneumonia, cytomegalovirus pneumonitis and salmonellosis in systemic lupus erythematosus Ann Rheum Dis 50 1991 811 812
95. Kattwinkel N. Cook L. Agnello V. Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis J Rheumatol 18 1991 79 81
96. Duffy K.N. Duffy C.M. Gladman D.D. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients J Rheumatol 18 1991 1180 1184
97. Bates J.H. Campbell D.G. Barron A.L. Microbial etiology of acute pneumonia in hospitalized patients Chest 101 1992 1005 1012
98. Koll B.S. Brown A.E. Changing patterns of infections in the immunocompromised patient with cancer Hemat Oncol Clin North Am 7 1993 753 769
99. Porges A.J. Beattie S.L. Ritchlin C. Patients with systemic lupus erythematosus at risk for pneumocystis carinii pneumonia J Rheumatol 19 1992 1191 1194
100. Liam C.-K. Wang F. Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus Lupus 1 1992 379 385
101. (letter) Lim P.D.R. Rowell R.J. Jonhston D.A. Pneumocystis carinii pneumonia following immunosuppressive therapy in systemic lupus erythematosus Br J Rheumatol 31 1992 643 644
102. Harisdangkul V. Songcharoen S. Lin A. Listerial infections in patients with systemic lupus erythematosus South Med J 85 1992 957 960
103. Kraus A. Cabral A.R. Sifuentes-Osornio J. Listeriosis in patients with connective tissue diseases J Rheumatol 21 1994 635 638
104. Nived O. Sturfelt G. Wollheim F. Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group Q J Med 55 1985 271 287
105. Walport M.J. Inherited complement deficiency: Clues to the physiological activity of complement in vivo Q J Med 86 1993 355 358
106. Gaines A.D. Buckley R.H. Impaired antibody response to polysaccharides in association with functional asplenia J Pediatr 114 1989 89 91
107. Oh H.M.L. Chng H.H. Boey M.L. Infections in systemic lupus erythematosus Singapore Med J 34 1993 406 408
108. Pablos J.L. Aragon A. Gomez-Reino J.J. Salmonellosis and systemic lupus erythematosus: Report of ten cases Br J Rheumatol 33 1994 129 132
109. Medina F. Fraga A. Lavalle C. Salmonella septic arthritis in systemic lupus erythematosus: The importance of chronic carrier state J Rheumatol 16 1989 203 208
110. van de Laar M.A.F.J. Meenhorst P.L. van Soesbergen R.M. Polyarticular Salmonella Bacterial Arthritis in a Patient with Systemic Lupus Erythematosus J Rheumatol 16 1989 231 234
111. Shahram F. Akbarian M. Davatchi F. Salmonella infection in systemic lupus erythematosus Lupus 2 1993 55 59
112. (letter) Hammoudeh M. Siam R.A. Salmonella peritonitis and splenic abscess in a patient with systemic lupus erythematosus Ann Rheum Dis 51 1992 140
113. Sanchez-Guerero J. Alarcon-Segovia D. Salmonella pericarditis with tamponade in systemic lupus erythematosus Br J Rheumatol 29 1990 69 71
114. Frayha R.A. Jizi I. Saadeh G. Salmonella typhimurium bacteruria: An increased infection rate in systemic lupus erythematosus Arch Intern Med 145 1985 645 647
115. (letter) Li K.E. Cohen M.G. Nontyphoidal salmonella ovarian abscess in systemic lupus erythematosus J Rheumatol 22 1995 575 576
116. Abramson S. Kramer S.B. Radin A. Salmonella bacteremia in systemic lupus erythematosus Arthritis Rheum 28 1985 75 79
117. Kraus A. Guerra-Bautista G. Alarcon-Segovia D. Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases: A dangerous complication of folk medicine J Rheumato1 18 1991 1328 1331
118. Li E.K. Cohen M.G. Ho A.K. Salmonella bacteraemia occurring concurrently with the first presentation of systemic lupus erythematosus Br J Rheumatol 32 1993 66 67
119. (letter) Martinez J.T. Vidaller A. Pac V. Systemic lupus erythematosus presenting as salmonella enteritidis bacteremia J Rheumatol 18 1991 785
120. Petros D. West S. Overwhelming pneumococcal bacteremia in systemic lupus erythematosus Ann Rheum Dis 48 1989 333 335
121. DiNubile M.J. Albornoz M.A. Stumacher R.J. Pneumococcal soft-tissue infections: Possible association with connective tissue diseases J Infect Dis 163 1991 897 900
122. Patel M. Ahrens J.C. Moyer D.V. Pneumococcal soft-tissue infections: A problem deserving more recognition Clin Infect Dis 19 1994 149 151
123. (letter) Carratala J. Moreno R. Cabellos C. Neisseria meningitidis monoarthritis revealing systemic lupus erythematosus J Rheumato1 15 1988 532 533
124. Abbas A.K. Lichtman A.H. Pober J.S. Immunity to microbes Abbas AK Lichtman A.H. Pober I.S. Cellular and Molecular Immunology ed 2 1994 Saunders Philadelphia, PA 319 336
125. Chanock S. Evolving risk factors for infectious complications of cancer therapy Hematol Oncol Clin North Am 7 1993 771 793
126. Rubin R.H. Ferraro M.J. Understanding and diagnosing infectious complications in the immunocompromised host Hematol Oncol Clin North Am 7 1993 795 812
127. Young L.S. Mycobacterial diseases and the compromised host Clin Infect Dis 17 suppl 2 1993 5436 5441
128. Feng P.H. Tan T.H. Tuberculosis in patients with systemic lupus erythematosus Ann Rheum Dis 41 1982 11 14
129. Skogberg K. Ruutu P. Tukiainen P. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis Clin Infect Dis 17 1993 1012 1017
130. Stecher D.R. Gusis S. Maldonado J.A. Tuberculous arthritis in the course of connective tissue disease: Report of 4 cases J Rheumatol 19 1992 1418 1420
131. Ingram C.W. Tanner D.C. Durack D.T. Disseminated infection with rapidly growing mycobacteria Clin Infect Dis 16 1993 463 471
132. Kahl L. Herpes zoster infections in systemic lupus erythematosus: Risk factors and outcome J Rheumatol 21 1994 84 86
133. Nagasawa K. Yamauchi Y. Tada Y. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis Ann Rheum Dis 49 1990 630 633
134. Feinman M.C. Friedberg M.A. Schwartz J.C. Central nervous system herpesirus infection in systemic lupus erythematosus: Diagnosis by endoretinal biopsy J Rheumatol 20 1993 1058 1061
135. Bulpitt K.J. Brahn E. Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: Diagnosis by antemortem skin biopsy J Rheumatol 16 1989 677 680
136. Ross C.N. Beynon H.L.C. Savill J.S. Ganciclovir treatment for cytomegalovirus infection in immunocompromised patients with renal disease Q J Med 81 1991 929 936
137. Bonafede R.P. van Staden M. Klemp P. Hepatitis B virus infection and liver function in patients with systemic lupus erythematosus J Rheumatol 13 1986 1050 1052
138. Lai F.M.-M. Lai K.-K. Lee J.C.K. Hepatitis B virus-related glomerulopathy in patients with systemic lupus erythematosus Am J Clin Pathol 88 1987 412 420
139. Barthel H.R. Wallace D.J. False-positive human immunodeficiency virus testing in patients with lupus erythematosus Semin Arthritis Rheum 23 1993 1 7
140. Davis P. Viral infections, acquired immunodeficiency syndrome, and rheumatic diseases Curr Opin Rheumatol 4 1992 529 533
141. Yeh C.-K. Fox P. Goto Y. Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus J Rheumatol 19 1992 1810 1812
142. Esteva M.H. Blasini A.M. Ogly D. False positive results for antibody to HIV in two patients with systemic lupus erythematosus Ann Rheum Dis 51 1992 1071 1073
143. Zimmerman B. Spiegel M. Lally E.V. Cryptococcal meningitis in systemic lupus erythematosus Semin Arthritis Rheum 22 1992 18 24
144. Molnar-Nadasdy G. Haesly I. Reed J. Placental cryptococcosis in a mother with systemic lupus erythematosus Arch Pathol Lab Med 118 1994 757 759
145. Weinberger M. Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies Hematol Oncol Clin North Am 7 1993 865 885
146. Janwityanuchit S. Krachangwongchai K. Totemchokchyakarn K. Infection in systemic lupus erythematosus J Med Assoc Thai 76 1993 542 548
147. Mok C.C. Lau C.S. Poon S.P. Primary nocardial meningitis in systemic lupus erythematosus Br J Rheumatol 34 1995 178 181
148. Ishibashi Y. Watanabe R. Hommura S. Endogenous Nocardia asteroides endophthalmitis in a patient with systemic lupus erythematosus Br J Ophthalmol 74 1990 433 436
149. Dubois E.L. Wallace D.J. Management of discoid and systemic lupus erythematosus Dubois E.L. Wallace D.J. Dubois' Lupus Erythematosus vol 3 1987 Lea & Febiger Philadelphia, PA 501 564
150. MacCabe R. Remington J.S. Toxoplasmosis The time has come N Engl J Med 318 1988 313 315
151. Wilcox M.H. Podell R.J. Pugh S.F. Toxoplasmosis and systemic lupus erythematosus Ann Rheum Dis 49 1990 254 257
152. Noel I. Balfour A.H. Wilcox M.H. Toxoplasma infection and systemic lupus erythematosus: Analysis of the serological response by immunoblotting J Clin Pathol 46 1993 628 632
153. Pawlowski T. Mackiewicz S.H. Machowska L. Toxoplasmosis and systemic lupus erythematosus: Comparative serological studies Z Rheumatol 50 1991 204 206
154. Godeau B. Coutant V. Huong D.L.T. Pneumocystis carinii pneumonia in the course of connective tissue disease: Report of 34 cases J Rheumatol 21 1994 246 251
155. Chayakul P. Thammakumpee G. Mitarnun W. Lung cavities from Pneumonocystis carinii in a patient with systemic lupus erythematosus J Med Assoc Thai 74 1991 310 312
156. Sneller M.C. Hoffman G.S. Talar-Williams C. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone Arthritis Rheum 38 1995 608 613
157. Inoue T. Takeda T. Koda S. Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis Rheumatol Int 6 1986 69 77
158. (abstr, suppl) Grana J. Freire M. DeToro J. Prospective study of 20 episodes of fever in 13 patients with systemic lupus erythematosus Arthritis Rheum 37 1994 S322
159. Carette S. Macher A.M. Nussbaum A. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: Ten years of experience at the National Institute of Health Semin Arthritis Rheum 14 1984 52 59
160. Smith P.R. Nacht R.I. Drug-induced lupus pleuritis mimicking pleural space infection Chest 101 1992 268 269
161. Klippel J.H. Rheumatology 1994 Mosby London 6.7.4 6.7.6
162. Flatauer F.E. Ballou S.P. Wollinsky E. Case report: Comparative response of fever to corticosteroids in tuberculosis and in connective tissue disease Am J Med Sci 281 1981 111 115
163. Stahl N.I. Klippel J.H. Decker J.L. Fever in systemic lupus erythematosus Am J Med 67 1979 935 940
164. Young B. Gleeson M. Cripps A.W. C-reactive protein: A. critical review Pathology 23 1991 118 124
165. Becker G.J. Waldburger M. Hughes G.R. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus Ann Rheum Dis 39 1980 50 52
166. (abstr, suppl) Middleton G.D. McFarlin J.E. Sipe J.D. C reactive protein in systemic lupus erythematosus: Elevation. does not predict infection Arthritis Rheum 37 1994 S321
167. Rettinger S.D. Hafenrichter D.G. Flye M.W. Clinical diagnostic applications of the polymerase chain reaction: Infection and rejection Arch Surg 128 1993 1253 1259
168. Clumeck N. Primary prophylaxis against opportunistic infection in patients with AIDS N Engl J Med 332 1995 739 740
169. Roilides E. Pizzo P.A. Modulation of host defenses by cytokines: Evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts Clin Infect Dis 15 1992 508 524
170. Roilides E. Pizzo P.A. Biological and hematopoietic cytokines in prevention or treatment of infections in immunocompromised hosts Hematol Oncol Clin North Am 7 1993 841 863
171. Kovacs J.A. Baseler M. Dewar R.J. Increases in CD4 T lymphocytes with intermittent courses of inteleukin-2 in patients with human immunodeficiency virus infection N Engl J Med 332 1995 567 575
172. Tolaymat A. Leventhal B. Sakarcan A. Systemic lupus erytbematosus in a child receiving long-term interferon therapy J Pediatr 120 1992 429 432
173. Schattner A. Lymphokines in autoimmunity Clin Immunol Immunopathol 70 1994 177 189
174. Wallace D.J. Podell T. Weiner J. Systemic lupus erythematosus-survival patterns: Experience with 609 patients JAMA 245 1981 934 938
175. Hadley A.G. Byron M.A. Chapel H.M. Antigranulocyte opsonic activity in sera from patients with systemic lupus erythematosus Br J Haematol 65 1987 61 65
176. Noguchi M. Iwamori M. Hirano T. Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus Ann Rheum Dis 51 1992 713 716
177. Perez H.D. Golstein I.M. Polymorphonuclear leukocyte chemotaxis in systemic lupus erythematosus J Rheumatol 14 suppl 13 1987 53 58
178. Jonsson H. Sturfelt G. A novel assay for neutrophil clustering activity of human sera: Relation to disease activity and neutropenia in systemic lupus erythematosus Ann Rheum Dis 49 1990 46 50
179. Yu C.-L. Tsai C.-Y. Sun K.-H. Increased spontaneous released of cytidine deaminase by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus Br J Rheumatol 31 1992 675 678
180. Molad Y. Buyon J. Anderson D.C. Intravascular neutrophil activation in systemic lupus erythematosus (SLE): Dissociation between increased expression of CD11b/CD18 and diminishedexpression of L-selectin on neutrophils from patients with active SLE Clin Immunol Immunopathol 71 1994 281 286
181. Linker-Israeli M. Cytokine abnormalities in human lupus Clin Immunol Immunopathol 63 1992 10 12
182. Perez D.H. Andron R.I. Goldstein I.M. Infection in patients with systemic lupus erythematosus Arthritis Rheum 22 1979 1326 1333
183. Wong K.L. Pattern of SLE in Hong Kong Chinese: A cohort study Scand J Rheumatol 21 1992 289 296
184. (abstr, suppl) Cardenas D. Salazar-Parano M. Orozco-Barocio G. Prevalence of tuberculosis in a Mexican population of patients with systemic lupus erythematosus Lupus 4 1995 85
185. abstr Victorio-Navarra S.T.G. Arroyo C.G. Torralba T. Tuberculosis among Filipino patients with systemic lupus erythematosus Lupus 4 suppl 2 1995 89
186. abstr Page B. Pneumocystis carinii pneumonia and systemic lupus erythematosus Lupus 4 suppl 2 1995 87